CONTENTS:
- Across the spectrum of legality: The market activities of influencers specialized in steroids and other performance and image enhancing drugs. Paoli L., Joseph Cox L.T., art. 104246.
- Social networks, secondary syringe exchange, and opioid agonist therapy retention among people who inject drugs in Hartford, CT. Zelenev A., Michael L., Li J., Altice F.L., art. 104250.
- Remaking the 'angry Narcanned subject': Affording new subject positions through take-home naloxone training. Ferguson N., Farrugia A., Moore D., Fraser S., art. 104253.
- Trends in use of medicines for opioid agonist treatment in Australia, 2013-2022. Bharat C., Chidwick K., Gisev N., Farrell M., Ali R., Degenhardt L., art. 104255.
- The relationship between cryptomarket drug purchase, social networks and adverse drug events: A cross-sectional study. Coney L., Peacock A., Malm A., Munksgaard R., Aldridge J., Ferris J.A., et al., art. 104258.
- Societal costs of illegal drug use in Sweden. Hofmarcher T., Leppänen A., Mansdotter A., Strandberg J., Hakansson A., art. 104259.
- The multiple makings of a supervised consumption service in a hospital setting. Long C., Guimond T., Bayoumi A.M., Firestone M., Strike C., art. 104260.
- Understanding problematic substance use among first responders during the COVID-19 pandemic: A survey of law enforcement, fire, and EMS workers in the United States. Witkowski K., Lofaro R.J., Headley A.M., Contreras S., Remington C.L., Ganapati N.E., art. 104261.
- Identifying policy options to regulate high potency cannabis: A multiple stakeholder concept mapping study in Washington State, USA. Carlini B.H., Garrett S.B., Matos P., Nims L.N., Kestens Y., art. 104270.
- Prevalence of methamphetamine use among gay, bisexual and other men who have sex with men: A systematic review and meta-analysis. Lodge W., Kelly P.J.A., Napoleon S., Plezia S., Mimiaga M.J., Biello K.B., art. 104271.
- Antisocial behavior in football matches: Do changes in alcohol sales policy increase violent acts? da Silva Dantas M.G., Sampaio L.M.B., Gasparetto T., art. 104273.
- Drug-related deaths at Australian music festivals. Santamarina R., Caldicott D., Fitzgerald J., Schumann J.L., art. 104274.
- Towards elimination of hepatitis C in Oslo: Cross-sectional prevalence studies among people who inject drugs. Opheim E., Dalgard O., Ulstein K., Sorli H., Backe O., Foshaug T., et al., art. 104279.
- Endocarditis, drug use and biological sex: A statewide analysis comparing sex differences in drug use-associated infective endocarditis with other drug-related harms. McCrary L.M., Cox M.E., Roberts K.E., Knittel A.K., Jordan R.A., Proescholdbell S.K., et al., art. 104280.
- On-site testing and treatment of sexually transmitted infections among female sex workers using molecular point-of-care testing integrated into harm reduction services in Madrid, Spain. Valencia J., Vazquez L., Lazarus J.V., Cuevas G., Torres-Macho J., Domingorena J., et al., art. 104281.
- The name and frame matters when it comes to public support of opioid prevention programs. Johnston J.B., Thompson K.A., art. 104282.
- Reimbursing incarcerated individuals for participation in research: A scoping review. Mambro A., Afshar A., Leone F., Dussault C., Stoové M., Savulescu J., et al., art. 104283.
- Low daily oral PrEP adherence and low validity of self-report in a randomized trial among PWID in Ukraine. Dumchev K., Kornilova M., Makarenko O., Antoniak S., Liulchuk M., Cottrell M.L., et al., art. 104284.
- Impact of non-medical cannabis legalization with market restrictions on health service use and incident cases of psychotic disorder in Ontario, Canada. Anderson K.K., Rodrigues R., Le B., Mamun M., Archie S., Edwards J., et al., art. 104285.
- Drug transactions and the dark web: Public perceptions of the locational setting of offenders and support for drug policy outcomes. Ireland L., Jardine E., art. 104286.
- Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure: An analysis of overdose and all-cause mortality. Bharat C., Gisev N., Barbieri S., Dobbins T., Larney S., Buizen L., et al., art. 104287.
- Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO study. Lopes S.S., Pericot-Valverde I., Arnsten J., Lum P.J., Taylor L.E., Mehta S.H., et al., art. 104288.
- Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019-2020. Tookes H.E., Bartholomew T.S., Sugar S.E.S., Plesons M.D., Bluthenthal R.N., Wenger L.D., et al., art. 104289.
- Motivators of and barriers to drug checking engagement in British Columbia, Canada: Findings from a cross-sectional study. Tobias S., Ferguson M., Palis H., Burmeister C., McDougall J., Liu L., et al., art. 104290.
- Waiting for inpatient detoxification: A qualitative analysis of patient experiences. Neale J., Cairns B., Gardiner K., Livingston W., McCarthy T., Perkins A., art. 104291.